It is a pharma private limited company based in Jaysingpur, Maharashtra, India, established in 2014.
2014 | Jaysingpur, Maharashtra, India | ActiveOxinium Pharmaceuticals Private Limited, a active private limited company, was established on 14 July 2014 in Jaysingpur, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999PN2014PTC151815. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.30 M.
It upholds a compliant status. Its leadership includes Anjali Satishkumar Patil (Director), Satishkumar Adgonda Patil (Director). Past directors included Sharad Adgonda Patil. Its latest AGM occurred on 30 October 2024, with the balance sheet filed on 31 March 2024. It is based at Patil Institute Ortho Sciences, Sa Nr S T Stand, Tal-Shirol, Jaysingpur, Jaysingpur, Maharashtra, 416101.
U74999PN2014PTC151815
151815
14 July 2014
₹1.00 M
₹0.30 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Oxinium Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anjali Satishkumar Patil | Director | 14 Jul 2014 | Current |
| Satishkumar Adgonda Patil | Director | 14 Jul 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 May 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Oxinium Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 42.67% increase. The company also saw a slight decrease in profitability, with a 2.55% decrease in profit. The company's net worth Soared by an impressive increase of 22.27%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Oxinium Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Oxinium Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Oxinium Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oxinium Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Oxinium Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Oct 2024 as per latest MCA records. was documented.
Progress on Oxinium Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was documented.
Anjali Satishkumar Patil was appointed as a Director was appointed as a Director on 14 Jul 2014 & has been associated with this company since 11 years 5 months . was recorded as a recent event.
Progress on Satishkumar Adgonda Patil was appointed as a Director was appointed as a Director on 14 Jul 2014 & has been associated with this company since 11 years 5 months . was documented.
The activity Oxinium Pharmaceuticals Private Limited was registered on 14 Jul 2014 with Roc Pune & aged 11 years 5 months as per MCA records. was completed.
The CIN of Oxinium Pharmaceuticals Private Limited is U74999PN2014PTC151815.
Oxinium Pharmaceuticals Private Limited is headquartered at Patil Institute Ortho Sciences, Sa Nr S T Stand, Tal-Shirol, Jaysingpur, Jaysingpur, Maharashtra, 416101.
Oxinium Pharmaceuticals Private Limited was incorporated on 14 July 2014.
The current directors of Oxinium Pharmaceuticals Private Limited are
The primary industry of Oxinium Pharmaceuticals Private Limited is Trade.
Oxinium Pharmaceuticals Private Limited is unlisted.
The authorized capital of Oxinium Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.30 M.
The compliance status of Oxinium Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX